Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -25.38% is 56% above its 5-year average of -58.07%, near the high end of its 5-year range (-113.76%–-25.38%).
As of the fiscal period ended Tuesday, June 30, 2026. 70.28% above its 12-month average of -85.38%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -25.38%.
RETURN ON INVESTED CAPITAL (ROIC)
-25.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-85.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-68.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-58.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-44.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+70.28%
CURRENT VS 3Y AVG
+63.08%
CURRENT VS 5Y AVG
+56.31%
CURRENT VS 10Y AVG
+43.17%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 666 covered companies
CURRENT VS SECTOR MEDIAN
+23.99%
vs the sector median at left
InflaRx N.V.
Market Cap
$241.56M
Return on Invested Capital (ROIC)
-25.38%
TTM Avg
-85.38%
3Y Avg
-68.73%
5Y Avg
-58.07%
Market Cap
$240.98M
Return on Invested Capital (ROIC)
-7.08%
TTM Avg
-12.89%
3Y Avg
-21.42%
5Y Avg
-39.95%
Market Cap
$240.97M
Return on Invested Capital (ROIC)
-69.76%
TTM Avg
-64.00%
3Y Avg
-45.05%
5Y Avg
-31.07%
Market Cap
$242.35M
Return on Invested Capital (ROIC)
-1718.59%
TTM Avg
-749.70%
3Y Avg
-566.74%
5Y Avg
-409.31%
Market Cap
$243.62M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-8.11%
3Y Avg
-7.60%
5Y Avg
-6.24%
Market Cap
$237.69M
Return on Invested Capital (ROIC)
1.38%
TTM Avg
-1.85%
3Y Avg
-13.83%
5Y Avg
-10.66%
Market Cap
$237.38M
Return on Invested Capital (ROIC)
-28.14%
TTM Avg
-28.34%
3Y Avg
-154.06%
5Y Avg
-154.06%
Market Cap
$246.67M
Return on Invested Capital (ROIC)
-701.55%
TTM Avg
-3723.51%
3Y Avg
-1911.77%
5Y Avg
-1278.48%
Market Cap
$235.50M
Return on Invested Capital (ROIC)
-16.87%
TTM Avg
-43.46%
3Y Avg
-51.45%
5Y Avg
-53.92%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InflaRx N.V. (IFRX) | $241.56M | -25.38% | -85.38% | -68.73% | -58.07% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $240.98M | -7.08% | -12.89% | -21.42% | -39.95% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.97M | -69.76% | -64.00% | -45.05% | -31.07% |
| Galectin Therapeutics Inc. (GALT)vs › | $242.35M | -1718.59% | -749.70% | -566.74% | -409.31% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | N/A | -8.11% | -7.60% | -6.24% |
| High Tide Inc. (HITI)vs › | $237.69M | 1.38% | -1.85% | -13.83% | -10.66% |
| BioAge Labs Inc. (BIOA)vs › | $237.38M | -28.14% | -28.34% | -154.06% | -154.06% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $246.67M | -701.55% | -3723.51% | -1911.77% | -1278.48% |
| MacroGenics, Inc. (MGNX)vs › | $235.50M | -16.87% | -43.46% | -51.45% | -53.92% |
| Invivyd, Inc. (IVVD)vs › | $247.82M | -59.90% | -142.39% | -118.24% | -103.50% |
ROIC
-25.4%
ROE
-27.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -25.38% |
| 2026-03-31 | -113.76% |
| 2025-12-31 | -111.05% |
| 2025-09-30 | -93.19% |
| 2025-06-30 | -83.52% |
| 2025-03-31 | -75.45% |
| 2024-12-31 | -89.28% |
| 2024-09-30 | -84.27% |
| 2024-06-30 | -63.65% |
| 2024-03-31 | -49.20% |
| 2023-12-31 | -42.70% |
| 2023-09-30 | -33.65% |
| 2023-06-30 | -28.41% |
| 2023-03-31 | -33.97% |
| 2022-12-31 | -35.81% |
| 2022-09-30 | -41.40% |
| 2022-06-30 | -43.49% |
| 2022-03-31 | -58.80% |
| 2021-12-31 | -45.75% |
| 2021-09-30 | -37.55% |
| 2021-06-30 | -29.29% |
| 2021-03-31 | -23.03% |
| 2020-12-31 | -40.92% |
| 2020-09-30 | -42.35% |
| 2020-06-30 | -52.87% |
| 2020-03-31 | -55.16% |
| 2019-12-31 | -52.57% |
| 2019-09-30 | -46.15% |
| 2019-06-30 | -36.67% |
| 2019-03-31 | -27.94% |
| 2018-12-31 | -25.39% |
| 2018-09-30 | -22.18% |
| 2018-06-30 | -18.48% |
| 2018-03-31 | -21.58% |
| 2017-12-31 | -15.77% |
| 2017-09-30 | -59.58% |
| 2017-06-30 | -47.14% |
| 2016-12-31 | -24.97% |
